Fig. 3From: Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in ChinaProportions of intraocular pressure (IOP) decreased by ≥ 1 mmHg at the last visit in Groups B and CBack to article page